• OPEN AN ACCOUNT
Indian Indices
Nifty
24,821.10 140.20
(0.57%)
Sensex
81,337.95 446.93
( 0.55%)
Bank Nifty
56,222.00 137.10
( 0.24%)
Nifty IT
35,373.25 3.20
( 0.01%)
Global Indices
Nasdaq
44,659.66 -198.91
(-0.44%)
Dow Jones
6,392.63 -18.14
(-0.28%)
Hang Seng
40,625.40 -372.87
(-0.91%)
Nikkei 225
9,136.32 54.88
(0.60%)
Forex
USD-INR
86.51 0.12
(0.14%)
EUR-INR
101.58 -0.03
(-0.03%)
GBP-INR
116.22 -0.77
(-0.66%)
JPY-INR
0.59 0.00
(-0.62%)

EQUITY - MARKET SCREENER

Lupin Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500257
INE326A01037
531.5470474
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
LUPIN
22.66
90634.66
EPS(TTM)
Face Value()
Div & Yield %
87.58
2
0.6
 

Dr Lal Pathlabs Ltd - Board Meeting Intimation for Declaration Of Financial Results For The Quarter Ended June 30 2025 And Interim Dividend If Any
Jul 24,2025
Dr. Lal Pathlabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2025 inter alia to consider and approve Un-audited Financial Results for the Quarter ended June 30 2025 and declaration of Interim Dividend if any for FY 2025-26